| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.69B | +0.9% |
| Cost of Revenue | $80.24B | +1.4% |
| Gross Profit | $17.45B | -1.2% |
| R&D Expense | $4.54B | +14.4% |
| SG&A Expense | $5.15B | +7.3% |
| Operating Income | $7.08B | -20.4% |
| Pre-tax Income | $8.99B | -9.9% |
| Income Tax | $1.84B | +136.7% |
| Net Income | $7.09B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.14B | -1.6% |
| Short-term Investments | $20.42B | +60.9% |
| Accounts Receivable | $4.42B | +25.9% |
| Inventory | $12.02B | -11.8% |
| Current Assets | $58.36B | +17.6% |
| Total Assets | $122.07B | +14.5% |
| Current Liabilities | $28.82B | +0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.92B | +12.6% |
| Capital Expenditures | $11.34B | +27.4% |
| Investing Cash Flow | -$18.79B | -20.6% |
| Financing Cash Flow | $3.85B | +48.8% |
| Free Cash Flow | $3.58B | -17.8% |
| -52.7% |
| EPS (Basic) | $2.23 | -52.9% |
| EPS (Diluted) | $2.04 | -52.6% |
| Long-term Debt |
| $5.54B |
| +106.4% |
| Total Liabilities | $48.39B | +12.5% |
| Stockholders' Equity | $72.91B | +16.4% |